Last: | $35.63 |
---|---|
Change Percent: | -0.57% |
Open: | $35.35 |
Close: | $35.63 |
High: | $35.81 |
Low: | $35.06 |
Volume: | 61,090 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$35.63 | $35.35 | $35.63 | $35.81 | $35.06 | 61,090 | 05-07-2024 |
$35.15 | $34.93 | $35.15 | $35.4607 | $34.75 | 43,529 | 05-06-2024 |
$34.87 | $35.08 | $34.87 | $35.195 | $34.47 | 55,554 | 05-03-2024 |
$34.97 | $34.82 | $34.97 | $35.13 | $34.107 | 59,355 | 05-02-2024 |
$34.64 | $34.38 | $34.64 | $34.86 | $33.784 | 47,808 | 05-01-2024 |
$34.25 | $34.15 | $34.25 | $34.5 | $33.62 | 48,956 | 04-30-2024 |
$34.3 | $33.85 | $34.3 | $34.53 | $33.85 | 55,160 | 04-29-2024 |
$33.81 | $33.48 | $33.81 | $33.87 | $33.3617 | 39,881 | 04-26-2024 |
$33.59 | $34.2 | $33.59 | $34.315 | $33.48 | 43,220 | 04-25-2024 |
$34.27 | $34.01 | $34.27 | $34.27 | $33.6423 | 42,446 | 04-24-2024 |
$34.24 | $33.56 | $34.24 | $34.645 | $33.56 | 74,201 | 04-23-2024 |
$33.69 | $33.87 | $33.69 | $34.55 | $33.615 | 39,683 | 04-22-2024 |
$34.03 | $32.67 | $34.03 | $34.37 | $32.08 | 68,390 | 04-19-2024 |
$32.87 | $33.16 | $32.87 | $33.52 | $32.69 | 55,569 | 04-18-2024 |
$33.32 | $35.84 | $33.32 | $35.84 | $33.25 | 41,923 | 04-17-2024 |
$34.36 | $33.99 | $34.36 | $34.91 | $33.94 | 35,120 | 04-16-2024 |
$34.22 | $34.01 | $34.22 | $34.34 | $33.68 | 40,341 | 04-15-2024 |
$34.1 | $34.79 | $34.1 | $35 | $33.8838 | 47,918 | 04-12-2024 |
$34.75 | $35.3214 | $34.75 | $35.3276 | $34.685 | 51,852 | 04-11-2024 |
$35.41 | $36.51 | $35.41 | $36.76 | $35.04 | 53,192 | 04-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
National Research Corporation Company Name:
NRC Stock Symbol:
NASDAQ Market:
National Research Corporation Website:
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2024. CEO Commentary Michael Hays, Chief Executive Officer, commented: “NRC continues to be strongly positioned for growth in our expanding markets. Our decades of benc...
MALVERN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with ...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...